Jean-­Marc Ferrero

18.5k citations
207 papers · 9.6k indexed · 7 hit papers · h-index 41
Topics
Cancer Treatment and Pharmacology (70 papers)Breast Cancer Treatment Studies (62 papers)HER2/EGFR in Cancer Research (45 papers)
Partner nations
FranceUnited StatesSpain

In The Last Decade

Jean-­Marc Ferrero

199 papers receiving 9.4k citations

Hit Papers

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive M...2012202620162021201520132012201220144008001.2k

Peers

Jean-­Marc Ferrero
Comparison fields: 5 of 120
  • Oncology 6.4k
  • Pulmonary and Respiratory Medicine 4.0k
  • Cancer Research 3.0k
  • Radiology, Nuclear Medicine and Imaging 2.0k
  • Molecular Biology 1.8k
Replace Nicholas J. Robert with:
Nicholas J. Robert United States
Shahneen Sandhu Australia
Christophe Massard France
Keyue Ding Canada
Denise A. Yardley United States
Nuhad K. Ibrahim United States
Daniel Morgensztern United States
Semiglazov Vf Russia
Étienne Brain France
Sunil Verma Canada
Jean-­Marc Ferrero relative to Nicholas J. Robert United States Nicholas J. Robert's profile →
Citations per field
00.5×
Nicholas J. Robert · 1×
Citations per year

Countries citing papers authored by Jean-­Marc Ferrero

Since Specialization
Citations

This map shows the geographic impact of Jean-­Marc Ferrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-­Marc Ferrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-­Marc Ferrero more than expected).

Fields of papers citing papers by Jean-­Marc Ferrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-­Marc Ferrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-­Marc Ferrero. The network helps show where Jean-­Marc Ferrero may publish in the future.

Co-authorship network of co-authors of Jean-­Marc Ferrero

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-­Marc Ferrero. A scholar is included among the top collaborators of Jean-­Marc Ferrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-­Marc Ferrero. Jean-­Marc Ferrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 3
5 0
6 3
7 28
8 3
9 25
10 7
11 4
12 142
13
Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trialbreakdown →
371
14 14
15
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 studybreakdown →
700
16 19
17
Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Studybreakdown →
539
18 113
19
Tolérance cardiaque des associations paclitaxel-anthracyclines dans le cadre de la prise en charge du cancer du sein
3
20
Neoadjuvant chemotherapy of locally advanced breast cancer: historical comparison of 4 sequential combinations
1

About Jean-­Marc Ferrero

Jean-­Marc Ferrero is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 207 papers that have together received 9.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (70 papers), Breast Cancer Treatment Studies (62 papers) and HER2/EGFR in Cancer Research (45 papers). The work is most often cited by research in Oncology (6.4k citations), Cancer Research (3.0k citations) and Pulmonary and Respiratory Medicine (4.0k citations). Jean-­Marc Ferrero has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Sung‐Bae Kim, Mario Campone, Sandra M. Swain, Javier Cortés, Emma Clark, Andreas Schneeweiß, Mark Benyunes, José Baselga, Eva Ciruelos and Graham Ross. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026